Trupanion EPS TRUP
Diluted earnings per share by quarter and over the last twelve months, from 2013.
- Last 12 months, to Jun 30, 2026
- $0.53
- Latest quarter, Q2 FY26
- $0.16
- −27% on a year earlier
- Fiscal year 2025
- $0.45
Trupanion's earnings per share was $0.53 over the twelve months to Jun 30, 2026, up 104% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.16, down 27% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.45 | n/a |
| FY2024 | −$0.23 | n/a |
| FY2023 | −$1.08 | n/a |
| FY2022 | −$1.10 | n/a |
| FY2021 | −$0.88 | n/a |
| FY2020 | −$0.15 | n/a |
| FY2019 | −$0.06 | n/a |
| FY2018 | −$0.04 | n/a |
| FY2017 | −$0.06 | n/a |
| FY2016 | −$0.24 | n/a |
| FY2015 | −$0.63 | n/a |
| FY2014 | −$6.04 | n/a |
| FY2013 | −$6.31 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.16 | −27% | $0.53 | |
| Q1 FY26 | $0.11 | n/a | $0.59 | |
| Q4 FY25 | $0.13 | +225% | $0.45 | |
| Q3 FY25 | $0.13 | +333% | $0.36 | |
| Q2 FY25 | $0.22 | n/a | $0.26 | |
| Q1 FY25 | −$0.03 | n/a | −$0.10 | |
| Q4 FY24 | $0.04 | n/a | −$0.23 | |
| Q3 FY24 | $0.03 | n/a | −$0.32 | |
| Q2 FY24 | −$0.14 | n/a | −$0.45 | |
| Q1 FY24 | −$0.16 | n/a | −$0.64 | |
| Q4 FY23 | −$0.05 | n/a | −$1.08 | |
| Q3 FY23 | −$0.10 | n/a | −$1.26 |
Against its peers
Companies in Healthcare nearest Trupanion's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TRUPTrupanion | $0.53 | +104% a year |
| CDRECadre | $0.81 | −14% a year |
| BVSBioventus | $0.77 | |
| USPHU S Physical Therapy | $0.88 | −63% a year |
| OMEROmeros | $1.52 | |
| HLFHerbalife | $1.55 | −51% a year |
| OMDAOmada Health | $0.06 | |
| PCRXPacira BioSciences | $0.35 | |
| ANABAnaptysbio | $4.57 | |
| STAAStaar Surgical | $0.07 | |
| PNTGPennant | $0.90 | +15% a year |
| Peer median | $0.84 |
Where Trupanion ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Trupanion
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.